BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24353088)

  • 21. Association between Ras association domain family 1A promoter methylation and esophageal squamous cell carcinoma: a meta-analysis.
    Yang JZ; Ji AF; Wang JS; Chen ZY; Wen SW
    Asian Pac J Cancer Prev; 2014; 15(9):3921-5. PubMed ID: 24935575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China.
    Zhou SL; Cui J; Fan ZM; Li XM; Li JL; Liu BC; Zhang DY; Liu HY; Zhao XK; Song X; Wang R; Yan ZC; Yi HX; Wang LD
    BMC Cancer; 2013 May; 13():259. PubMed ID: 23705663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: Meta-analysis and TCGA analysis.
    Hu F; Chen L; Bi MY; Zheng L; He JX; Huang YZ; Zhang Y; Zhang XL; Guo Q; Luo Y; Tang WR; Sheng MM
    Pathol Res Pract; 2020 Aug; 216(8):153009. PubMed ID: 32703486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
    Tokinaga K; Okuda H; Nomura A; Ashida S; Furihata M; Shuin T
    Oncol Rep; 2004 Oct; 12(4):805-10. PubMed ID: 15375503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Genetic and Epigenetic Markers to Improve Differential Diagnosis of Prostate Cancer and Benign Prostatic Hyperplasia by Noninvasive Methods in Mexican Patients.
    Sánchez BE; Aguayo A; Martínez B; Rodríguez F; Marmolejo M; Svyryd Y; Luna L; Muñoz LA; Jiménez MA; Sotomayor M; Vargas V F; Mutchinick OM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e867-e877. PubMed ID: 29571584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
    Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
    Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studies.
    Wang HL; Liu P; Zhou PY; Zhang Y
    Ann Hum Genet; 2014 May; 78(3):208-16. PubMed ID: 24621386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis.
    Wang J; Wang B; Chen X; Bi J
    Carcinogenesis; 2011 Mar; 32(3):411-6. PubMed ID: 21156971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis.
    Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
    Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R; Ferdinand L; Reis IM; Schlesselman JJ
    Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data.
    Liu WJ; Tan XH; Guo BP; Ke Q; Sun J; Cen H
    Asian Pac J Cancer Prev; 2013; 14(6):3719-24. PubMed ID: 23886171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
    Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
    Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG island promoter hypermethylation of Ras association domain family 1A gene contributes to gastric carcinogenesis.
    Joo MK; Kim KH; Park JJ; Yoo HS; Choe J; Kim HJ; Lee BJ; Kim JS; Bak YT
    Mol Med Rep; 2015 Apr; 11(4):3039-46. PubMed ID: 25483734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of RASSF1A hypermethylation in prostate cancer].
    Wang YC; Yu ZH; Chen LB
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):822-5. PubMed ID: 17929562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.